The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Amino acids and mTORC1: from lysosomes to disease
Open accessAbstract
The mechanistic target of rapamycin (mTOR) kinase controls growth and metabolism, and its deregulation underlies the pathogenesis of many diseases, including cancer, neurodegeneration, and diabetes. mTOR complex 1 (mTORC1) integrates signals arising from nutrients, energy, and growth factors, but how exactly these signals are propagated await to be fully understood. Recent findings have placed the lysosome, a key mediator of cellular catabolism, at the core of mTORC1 regulation by amino acids. A multiprotein complex that includes the Rag GTPases, Ragulator, and the v-ATPase forms an amino acid-sensing machinery on the lysosomal surface that affects the decision between cell growth and catabolism at multiple levels. The involvement of a catabolic organelle in growth signaling may have important implications for our understanding of mTORC1-related pathologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The activation of the pro-aging and pro-cancer mTOR pathways is modulated by energy intake but also by a cocktail of different essential amino acids, with the branched-chain amino acids leucine and isoleucine playing a fundamental role (82).”
From Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms (2018) · cites this paper as [82]
In the citing paper
“AMPK has a direct inhibitory action on raptor, the adaptor protein for mTORC1, and can also stimulate the tuberous sclerosis complex TSC1/2 (164).”
From Placental Origins of Chronic Disease (2016) · cites this paper as [164]
In the citing paper
“More recent research has identified a Ragulator-RAG GTPases multiprotein complex associated with the lysosomal surface that regulates mTOR activity by controlling its sub-cellular location, recruiting it to the lysosome (164).”
From Placental Origins of Chronic Disease (2016) · cites this paper as [164]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509 · cited 1×
“In skeletal muscle, glucose import is suppressed and skeletal muscle waste ensues as a consequence (reviewed in [75]).”
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774 · cited 1×
“In addition, it is intriguing that only a very few mutations in mTOR have been found in human sporadic cancers [100,101].”
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227 · cited 2×
“Furthermore, aberrant mTORC1 potently suppresses autophagy, which may play a role in tumor suppression [62,63,79].”
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941 · cited 1×
“The mTOR kinase nucleates two distinct core complexes that have different kinase specificity and distinct protein partners (reviewed in [2]).”
Self-citationTSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914 · cited 8×
“The DNA damage response, a signal cascade that is initiated by the detection of DNA double-strand breaks and other genetic insults, culminates in activation of the tumor suppressor transcription factor p53, which transactivates AMPK and TSC2, contributing to mTORC1 inhibition [13,14].”
BackgroundInfluentialAMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849 · cited 2×
“In parallel, AMPK phosphorylates Raptor [12], leading to direct inhibition of mTORC1, possibly through structural destabilization of the complex.”
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766 · cited 1×
“Manipulating mTORC1 activity in this way may also prove important for anti-aging purposes, as suggested by the fact that rapamycin delays aging in mammals [106,107].”
BackgroundTemsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
Hudes, G. R., Carducci, M. A., Tomczak, P., Dutcher, J. P., Figlin, R. A., Kapoor, A., Starosławska, E., Sosman, J. A., McDermott, D. F., Bodrogi, I., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066838 · Cited by 3,645 · cited 1×
“Despite minimal side effects and outstanding pharmacokinetics, rapamycin has efficacy against only a few pathologies associated with high levels of mTORC1 activity, such as renal cell carcinoma [102] and tuberous sclerosis [103–105].”
Autophagy and the Integrated Stress Response
Kroemer, G., Mariño, G., & Levine, B. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.023 · Cited by 3,506 · cited 2×
“Moreover, it was observed that amino acid withdrawal from cells and organisms triggered autophagy, a process of cellular self-eating where pre-existing proteins and organelles are broken down into simpler metabolites via lysosomal degradation [21].”
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–435 of 435
Cell Cycle Progression Effects of Albumin
Uddin, S. (2021) · CUNY Academic Works (City University of New York)
Molecular structure of stress granules and their role in the eukaryotic cell
Pietras, P., Leśniczak-Staszak, M., Sowiński, M., & Szaflarski, W. (2021) · Medical Journal of Cell Biology · doi:10.2478/acb-2021-0006
The Landscape of Subcellular Long Non-coding RNAs Links Organelle Metabolic HomeostasisPreprint
Sang, L., Ju, H., Yang, Z., Ge, Q., Zhang, Z., Liu, F., Yang, L.-J., Gong, H., Shi, C., Qu, L., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-78018/v1
Mintser, O. P., & Новик, А. М. (2022) · Medical Informatics and Engineering · doi:10.11603/mie.1996-1960.2021.3-4.12637
Advances in the Regulation of Autophagy
夏, 丹. (2019) · Advances in Clinical Medicine · doi:10.12677/acm.2019.93027
Hou, F. F., & Nie, J. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732450740.793549178
Mitogenic and Metabolic signals regulate mTOR complex 1 function to control GSK3β nuclear program
Bautista, S. J. (2021) · doi:10.32920/ryerson.14654061.v1 · Cited by 1
Faculty Opinions recommendation of Leucine Signals to mTORC1 via Its Metabolite Acetyl-Coenzyme A.
Bogan, J. S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733953691.793554906
Müller, R. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.725409572.793572493
Kim, D., Park, G., Huuhtanen, J., Lundgren, S., Khajuria, R., Hurtado, A., Muñoz‐Calleja, C., Cardenoso, L., de Sora, V., Chen-Liang, T., et al. (2020) · immuneACCESS · doi:10.21417/dk2020nc
mTORC1: Upstream and Downstream
Yao, Y., & Inoki, K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00182-6
Hipolito, V. E. B., Diaz, J. A., Tandoc, K. V., Oertlin, C., Ristau, J., Chauhan, N., Sarić, A., McLaughlan, S., Larsson, O. S., Topisirović, I., et al. (2023) · doi:10.32920/21982928
Hipolito, V. E. B., Diaz, J. A., Tandoc, K. V., Oertlin, C., Ristau, J., Chauhan, N., Sarić, A., McLaughlan, S., Larsson, O. S., Topisirović, I., et al. (2023) · doi:10.32920/21982928.v1
Su, J.-Y., Chen, Y., Zhang, W., Zhang, R., Liu, T.-F., Yang, X., & Fang, Z. (2023) · Research Square · doi:10.21203/rs.3.rs-2993446/v1
Vanweert, F. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20231117fv · Cited by 1
Regulation of tumor microenvironment by nutrient trafficking
Kumar, S., Batra, G., Bansal, S., Prabha, P. K., Kaur, H., Prakash, A., Kuhad, A., & Medhi, B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95116-6.00016-5
Su, J.-Y., Chen, Y., Zhang, W., Zhang, R., Liu, T.-F., Luo, W.-M., Yang, X., & Fang, Z. (2024) · EngMedicine · doi:10.1016/j.engmed.2024.100022
Responses of Chick Myoblast Proliferation to Branched‐Chain Amino Acids in a Three‐Component System
Soma, K., Kikusato, M., Sato, K., & Toyomizu, M. (2025) · Animal Science Journal · doi:10.1111/asj.70106
Dholey, Y., Chowdhury, G., Panja, P., & Adak, S. (2026) · FEBS Letters · doi:10.1002/1873-3468.70283
“For an example, the multiprotein complex mTORC1 is present in the cytosol under limited concentration of amino acids and is translocated to the lysosomal membrane at high concentration of amino acids [57,58].”
Role of p27/Kip1 in auphagy under metabolic stress conditions
Nowosad, A. (2018) · theses.fr (ABES) · doi:10.70675/11eb36d1zc3baz4d74z8d00zc049667c5976
Functional characterization of the GATOR1 complex in cisplatin resistance
Pan, Z. (2024) · theses.fr (ABES) · doi:10.70675/2ddcf286zc553z40fdzb34ez875b3288c76b
Chiu, T.-Y., Hall, P.-R., Lazar, D. C., Kim, A., Forli, S., Ward, A. B., Teijaro, J. R., & Parker, C. G. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.04.729981
Amino-acids-mTORC1-driven DDA1 phosphorylation promotes DNA repair and glioblastoma progression
Chen, X., Wang, Z., An, Y., Liu, Y., Zhu, R., Li, L., Xu, D., Liu, R., Zhan, X., Yin, B., et al. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-03028-2
Yakin, J., Alam, F., & Elpa, J. F. G. (2026) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2026.2710420
mTOR-Mediated Neuron–Cancer Interactions
Nyarkoh, J. K., Wolan, M. J., & Feliciano, D. M. (2026) · Kinases and Phosphatases · doi:10.3390/kinasesphosphatases4030024
“They form a GTPase-activating GTPase-activating mTORC1 translocates and colocalizes with Rheb at the lysosome [30–32].”
Bioelectric regulation of stem cell fate: From the plasma membrane to organelles
Jester, A. G., Lin, B. C., & Piggott, B. J. (2026) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2026.102687
Caloric restriction’s molecular pathways: Unlocking neuroprotection in neurodegenerative diseases
MITKARI, M., Pawar, A., Hulwale, A., Shelke, V., Vyavahare, S., Doke, R. R., & Singh, S. (2026) · PharmaNutrition · doi:10.1016/j.phanu.2026.100543
BindingDB (2021) · UC San Diego · doi:10.7270/q2n87f26
Metadata
- Authors
- Efeyan, A., Zoncu, R., & Sabatini, D. M.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Zoncu, Roberto
- Sabatini, David M.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2012-09
- Volume
- 18
- Issue
- 9
- Pages
- 524-533
- ISSN
- 1471-4914 (ISSN-L)
- PMC
- PMC3432651
- OpenAlex
- W2059716825
- Cited by
- 436
- References
- 112
- Citations by year
- 2026: 13 · 2025: 8 · 2024: 14 · 2023: 21 · 2022: 22 · 2021: 36 · 2020: 34 · 2019: 29 · 2018: 29 · 2017: 36 · 2016: 50 · 2015: 60 · 2014: 52 · 2013: 31 · 2012: 1
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Trends in Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-nd)
- PMC
- Funders
- Howard Hughes Medical Institute
- Ellison Medical Foundation
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
- National Institutes of Health (CA129105)
- National Cancer Institute (R01CA103866, R01CA129105)
- National Institute of Allergy and Infectious Diseases (R37AI047389)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- mTORC1, amino acid signaling, lysosomes, Rag GTPases, Ragulator complex, V-ATPase, nutrient sensing, cancer, neurodegeneration, diabetes mellitus
- MeSH terms
- Mechanistic Target of Rapamycin Complex 1, Amino Acids, Diabetes Mellitus, Humans, Lysosomes, Neoplasms, Neurodegenerative Diseases, Multiprotein Complexes, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
